Moreover, the effect of the herein described DNA-based dietary intervention could be explored in other clinical conditions where glucose management is impaired, for instance in individuals with T2DM (insulin independent or dependent), or individuals with Type 1 Diabetes. This evidence concerns the gene INS and type 1 diabetes mellitus.